CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 77 filers reported holding CASCADIAN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $11,593,000 | -9.5% | 3,133,224 | 0.0% | 1.40% | -14.2% |
| Q3 2017 | $12,815,000 | +10.1% | 3,133,224 | 0.0% | 1.63% | -9.9% |
| Q2 2017 | $11,640,000 | -10.3% | 3,133,224 | 0.0% | 1.81% | -18.0% |
| Q1 2017 | $12,972,000 | -3.9% | 3,133,224 | 0.0% | 2.21% | -18.7% |
| Q4 2016 | $13,504,000 | – | 3,133,224 | – | 2.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 925,000 | $3,432,000 | 2.73% |
| EcoR1 Capital, LLC | 3,000,000 | $11,145,000 | 1.98% |
| BVF INC/IL | 3,133,224 | $11,640,000 | 1.81% |
| Sandia Holdings, LLC | 927,264 | $3,445,000 | 1.61% |
| NEA Management Company, LLC | 9,064,575 | $33,675,000 | 1.22% |
| Anson Funds Management LP | 981,428 | $3,646,000 | 1.15% |
| Avoro Capital Advisors LLC | 1,821,248 | $6,766,000 | 0.85% |
| Redmile Group, LLC | 3,735,994 | $13,879,000 | 0.84% |
| FT Options LLC | 127,429 | $473,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 681,210 | $2,531,000 | 0.43% |